Internal Medicine · Burlingame, CA
NPI
1275532145
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1828 El Camino Real, Suite 406
Burlingame, CA, 94010
Phone (650) 692-1388
Groups this clinician bills Medicare through
Medicare paid, 2024
$586K
8,405 services
Medicare patients, 2024
530
Average age 78
Drug cost, 2024
$2.3M
18,804 prescriptions
Company payments, 2025
$3,576
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Simon K Lee was code 99213 (office e&m - established), 2,205 times for 467 patients. In total Simon K Lee billed 8,405 services in 49 codes, and Medicare paid $586K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,205 | 467 | $62.17 | $137K |
| 99214 Office E&M - Established | Office | 895 | 378 | $102.37 | $92K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 709 | 129 | $57.19 | $41K |
| 99454 E&M - Miscellaneous | Office | 464 | 70 | $50.94 | $24K |
| 99483 Office/Outpatient Services | Office | 429 | 426 | $169.02 | $73K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 429 | 420 | $18.42 | $7,901 |
| 99497 Care Management/Coordination | Office | 428 | 414 | $65.84 | $28K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 409 | 405 | $27.80 | $11K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 408 | 408 | $155.58 | $63K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 390 | 383 | $17.99 | $7,017 |
| G0008 Administration of influenza virus vaccine | Office | 205 | 198 | $38.68 | $7,929 |
| 96372 Injection Administration | Office | 174 | 39 | $13.91 | $2,420 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 156 | 29 | $0.98 | $153 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 140 | 69 | $45.42 | $6,359 |
| 91320 Vaccine Product | Office | 111 | 100 | $148.18 | $16K |
By year: 2022 $631K for 8,732 services; 2023 $575K for 8,745 services; 2024 $586K for 8,405 services.
Medicare prescription drug claims, 2024
In 2024, the drug Simon K Lee prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,661 prescriptions and refills. In total Simon K Lee wrote 18,804 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,661 | 4,753 | 510 | $28K |
| Amlodipine Besylate Generic | 1,350 | 3,823 | 405 | $11K |
| Losartan Potassium Generic | 1,188 | 3,409 | 342 | $15K |
| Metformin Hcl Generic | 665 | 1,961 | 209 | $7,116 |
| Metoprolol Succinate Generic | 618 | 1,685 | 179 | $9,774 |
| Triamcinolone Acetonide Generic | 417 | 507 | 201 | $3,695 |
| Pantoprazole Sodium Generic | 377 | 1,030 | 146 | $9,252 |
| Omeprazole Generic | 340 | 981 | 127 | $7,994 |
| Alendronate Sodium Generic | 328 | 906 | 107 | $3,584 |
| Gabapentin Generic | 290 | 637 | 117 | $5,113 |
| Tamsulosin Hcl Generic | 276 | 782 | 88 | $6,101 |
| Simvastatin Generic | 273 | 789 | 76 | $4,211 |
| Jardiance Empagliflozin | 263 | 625 | 71 | $351K |
| Hydrochlorothiazide Generic | 259 | 751 | 74 | $1,099 |
| Lisinopril Generic | 238 | 694 | 73 | $2,295 |
Brand drugs: 2,207 claims; generic drugs: 16,515 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Simon K Lee $3,576 ($3,576 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $794.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 16 | $794 |
| GlaxoSmithKline, LLC. GSK | 17 | $451 |
| Novo Nordisk Inc NVO | 11 | $356 |
| Amgen Inc. AMGN | 10 | $310 |
| Abbvie Inc. ABBV | 8 | $302 |
| Pfizer Inc. PFE | 7 | $258 |
| Gilead Sciences, Inc. GILD | 4 | $186 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $170 |
| Kowa Pharmaceuticals America, Inc. | 3 | $161 |
| Lilly USA, LLC LLY | 4 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.